And CharlieBulls post #75018224, which discusses Bell Potter's estimate of share value if a 'trade sale' was to occur:
"....our reasonable estimate of Enterprise value in a trade sale is ~US$3bn today (EV A$4.7bn after adjusting for cash) ie A$15/Share
01/08/2024.
"Being a biotechnology stock carrying significant risk biotechnology risk, our valuation is limited to 100% upside from the current market price. Revised valuation is $10/share and we retain our Buy (Speculative) rating."
And CharlieBulls post #75018224, which discusses Bell Potter's...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.89 |
Change
0.220(2.87%) |
Mkt cap ! $2.522B | |||
| Open | High | Low | Value | Volume |
| $7.70 | $7.97 | $7.54 | $8.004M | 1.025M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 733 | $7.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.89 | 4950 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |